Bevacizumab/Irinotecan Regimen

Preferred Label : Bevacizumab/Irinotecan Regimen;

NCIt synonyms : Irinotecan/Bevacizumab; Irinotecan-Bevacizumab; Irinotecan-Bevacizumab Regimen; Irinotecan/Avastin Regimen; Irinotecan-Avastin Regimen; Irinotecan/Bevacizumab Regimen;

NCIt related terms : Irinotecan and Bevacizumab; Irinotecan and Bevacizumab-maly; Irinotecan and Bevacizumab-onbe; Irinotecan and Bevacizumab-adcd; Irinotecan and Bevacizumab-bvzr; Irinotecan and Bevacizumab-equi; Irinotecan and Bevacizumab-awwb; Irinotecan and Bevacizumab-aybi;

NCIt definition : A regimen consisting of irinotecan and bevacizumab that can be used for the treatment of colorectal cancer and appendiceal adenocarcinoma.;

NCI Metathesaurus CUI : CL523569;

Codes from synonyms : 3393; 127587; 127143; 127365; 127513; 127217; 127439; 127291;

Details

Origin ID

C136258;

UMLS CUI

C4526531;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Colorectal Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients